Detailed Information
Cited 23 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up results from the JAVELIN Bladder 100 trial.
- Authors
- Powles, T[Powles, Thomas]; Park, SH[Park, Se Hoon]; Voog, E[Voog, Eric]; Caserta, C[Caserta, Claudia]; Perez-Valderrama, B[Perez-Valderrama, Begona]; Gurney, H[Gurney, Howard]; Loriot, Y[Loriot, Yohann]; Sridhar, SS[Sridhar, Srikala S.]; Tsuchiya, N[Tsuchiya, Norihiko]; Sternberg, CN[Sternberg, Cora N.]; Bellmunt, J[Bellmunt, Joaquim]; Aragon-Ching, JB[Aragon-Ching, Jeanny B.]; Petrylak, DP[Petrylak, Daniel P.]; Blake-Haskins, A[Blake-Haskins, Andy]; Laliberte, RJ[Laliberte, Robert J.]; Wang, J[Wang, Jing]; Costa, NM[Costa, Nuno Matos]; Grivas, P[Grivas, Petros]
- Issue Date
- 20-Feb-2022
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.40, no.6
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 40
- Number
- 6
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.